Change and step-down of combination treatment in asthma
Clinicians are often hesitant to change or reduce treatment in patients with asthma, especially when their symptoms are well-controlled. For such patients, this can mean over-treatment with unnecessarily high doses of corticosteroids or bronchodilators. In addition, patients might not get to try new, alternative treatments to decide which treatment works best for their individual needs. Research […]
Predicting patients with COPD who are likely to exacerbate – is it feasible in primary care?
Freeman D, Price D, Jones R, Kerkhof M
NPJ Prim Care Respir Med 2014; 24(14073): Abstract No – 06.
Investigating the proportion of community-based patients with COPD who meet eligibility criteria for published clinical trials of long-acting bronchodilator therapy for COPD: pilot phase
Halpin D, Bichel K, von Ziegenweidt J, Ali M, Price DB
NPJ Prim Care Respir Med 2014; 24(14073): Abstract No – 07.
Blood eosinophils as a marker of COPD
Kerkhof M, Price D, Postma D, Papi A, Brusselle G, Agusti A, Anzueto A, Vogelmeier C, Ryan D, Freeman D, Thomas M, Pavord I, Bafadhel M, Roche N, Jones R, Popov T, Pizzichini E, Rigazio A
NPJ Prim Care Respir Med 2014; 24(14073): Abstract No – 10.
Real life effectiveness of changing fixed-dose combination therapy from Seretides metered dose inhaler (MDI) to Flutiforms in UK patients with asthma
Lim D, Small I, Wolfe S, Hamill J, Gruffydd-Jones K, Daly C, Price D
NPJ Prim Care Respir Med 2014; 24(14073): Abstract No – 12.
Relationships between database-recorded objective variables and GINA current control status
Martin R, Burden A, Dima A, Colice G, Pizzichini E, Popov T, Papadopoulos N, Reddel H, Kaplan A, Holbrook J, Brusselle G, Price D
NPJ Prim Care Respir Med 2014; 24(14073): Abstract No – 13.
Episode pattern and healthcare utilisation in patients with seasonal allergic rhinitis
Pitman R, Paracha N, Parker C, Acaster S, Bachert C, Bousquet J, Price D
NPJ Prim Care Respir Med 2014; 24(14073): Abstract No – 14.
Dynamics of treatment within a year in patients diagnosed with either allergic, non-allergic rhinitis or hay fever over the period 1992–2012
Price D, Scadding GK, Bachert C, Saleh H, Nasser S, Bichel K, Carter V, Von Ziegenweidt J, Ryan D
NPJ Prim Care Respir Med 2014; 24(14073): Abstract No – 19.
Identifying factors, including biomarkers, associated with future asthma exacerbation and hospitalisation risk from routine UK primary care clinical records
Price DB, Bleecker ER, Campbell JD, Corrigan CJ, Pavord ID, Wenzel SE, Thomas M, Clark A, Chisholm A, Rigazio A, Burden A, Ashton VL, Wilson AM; on behalf of the Respiratory Effectiveness Group
NPJ Prim Care Respir Med 2014; 24(14073): Abstract No – 21.